← Back to Search

Sleep Restriction for Sleep Deprivation

Q: Does my particular profile qualify me to participate in this experiment?

<p>This clinical trial seeks 66 individuals with <a href="https://www.withpower.com/clinical-trials/obesity">obesity</a>, between the ages of 20 and 75. To qualify for this research opportunity, applicants must meet a set of requirements: they should normally <a href="https://www.withpower.com/clinical-trials/sleep">sleep</a> 7-9 hours nightly; have a BMI in the range 25-29.9 kg/m2; possess at least one <a href="https://www.withpower.com/clinical-trials/overweight">overweight</a> parent; be free from any current or past <a href="https://www.withpower.com/clinical-trials/mental-health">mental health</a> conditions such as eating disorders, <a href="https://www.withpower.com/clinical-trials/diabetes">diabetes</a> or CVD (as indicated by normal scores on relevant questionnaires); and belong to all racial/ethnic groups.</p>

N/A

Waitlist Available

Led By Marie-Pierre St-Onge, PhD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up weeks 5 and 6 (endpoint)

Awards & highlights

Study Summary

This trial will look at the effects of not getting enough sleep over time on mood, thinking, and physical performance.

Who is the study for?

This trial is for adults with a BMI of 25-29.9 who sleep normally (7-9 hours) and have at least one obese parent. Participants should not have any history of sleep, psychiatric disorders, or major health issues like diabetes or heart disease. Smokers, shift workers, frequent travelers across time zones, heavy equipment operators, and those with high caffeine intake are excluded.Check my eligibility

What is being tested?

The study examines the impact of long-term sleep restriction on mood and cognitive as well as physical performance in adults. It aims to understand how reduced sleep over an extended period affects daily functioning.See study design

What are the potential side effects?

While the trial itself does not involve medication that could cause side effects, participants may experience increased tiredness, irritability or changes in mood and alertness due to the imposed sleep restriction.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weeks 5 and 6 (endpoint)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weeks 5 and 6 (endpoint)

This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 5 and 6 (endpoint) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Fat Mass

Secondary outcome measures

Appetite-regulating hormones

Energy Expenditure (EE)

Neuronal activity

+1 more

Other outcome measures

Activity

Immune function

Immune markers

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Sleep Restriction (SR)Experimental Treatment1 Intervention

Participants will be asked to keep their habitual wake time constant but delay their bedtime to achieve a reduction of 1.5 hours in total sleep time during the sleep restriction (SR) phase.

Group II: Habitual Sleep (HS)Active Control1 Intervention

Participants will be asked to follow a fixed bedtime routine based on the participant's regular bed- and wake-times during the habitual sleep (HS) phase.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sleep Restriction (SR)

2016

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,433 Previous Clinical Trials

2,450,970 Total Patients Enrolled

2 Trials studying Sleep Deprivation

34 Patients Enrolled for Sleep Deprivation

NYU Langone HealthOTHER

1,368 Previous Clinical Trials

839,681 Total Patients Enrolled

2 Trials studying Sleep Deprivation

180 Patients Enrolled for Sleep Deprivation

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,837 Previous Clinical Trials

47,851,582 Total Patients Enrolled

12 Trials studying Sleep Deprivation

4,809 Patients Enrolled for Sleep Deprivation

Media Library

Sleep Restriction (SR) Clinical Trial Eligibility Overview. Trial Name: NCT02960776 — N/A

Sleep Deprivation Research Study Groups: Habitual Sleep (HS), Sleep Restriction (SR)

Sleep Deprivation Clinical Trial 2023: Sleep Restriction (SR) Highlights & Side Effects. Trial Name: NCT02960776 — N/A

Sleep Restriction (SR) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02960776 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can join this investigation?

"Affirmative. Clinicaltrials.gov reveals that this research is actively soliciting volunteers; the trial has been posted since November 1st 2016 and was last updated on April 4th 2022. The study necessitates 66 participants to be recruited from a single clinical site."

Answered by AI

Is this research endeavor still open to recruitment of participants?

"Clinical trials.gov states that this particular study is currently enrolling patients. The trial's inception dates back to November 1st 2016 and was recently amended on April 4th 2022."

Answered by AI

Does my particular profile qualify me to participate in this experiment?

"This clinical trial seeks 66 individuals with obesity, between the ages of 20 and 75. To qualify for this research opportunity, applicants must meet a set of requirements: they should normally sleep 7-9 hours nightly; have a BMI in the range 25-29.9 kg/m2; possess at least one overweight parent; be free from any current or past mental health conditions such as eating disorders, diabetes or CVD (as indicated by normal scores on relevant questionnaires); and belong to all racial/ethnic groups."

Answered by AI